跳转至内容
Merck
CN

24217-U

VOCOL® 毛细管GC色谱柱

L × I.D. 60 m × 0.32 mm, df 1.80 μm

别名:

熔融石英毛细管,VOCOL® 60m×0.32mm,1.8μm(研发产品)

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
77101502
NACRES:
SB.54
eCl@ss:
32119290
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

material

fused silica

agency

EPA TO-17,502.2,624,8015,8260,OLM04.2 VOA,524.2, NIOSH 1003

parameter

≤25-250 °C temperature (isothermal or programmed)

Beta value

44

df

1.80 μm

technique(s)

gas chromatography (GC): suitable

L × I.D.

60 m × 0.32 mm

application(s)

environmental
food and beverages
forensics and toxicology
industrial hygiene

column type

capillary intermediate polar

Quality Level

正在寻找类似产品? 访问 产品对比指南

General description

应用:这种被设计用于挥发性有机化合物(VOC)分析的中间极性色谱柱可为高挥发性化合物提供较高的保留时间和分辨率。可直接通过进样端口或偶联至吹扫捕集系统而使用该色谱柱。
USP代码:非

  • 结合
  • 永久
温度。限制
  • ≤0.32 mm I.D., <2 μm: 亚常温至250 °C (等温或程序性的)
  • ≤0.32 mm I.D., ≥2 μm: 亚常温至230 °C (等温或程序性的)
  • ≥0.53 mm I.D., <2 μm: 亚常温至250 °C (等温或程序性的)
  • ≥0.53 mm I.D., ≥2 μm: 亚常温至230 °C (等温或程序性的)

Application

VOCOL®毛细管柱(具有交联基团的二苯基二甲基聚硅氧烷)可用于吹扫捕集和气相色谱-质谱(GC/MS)法分析34种挥发性有机物。它还被发现其适用于全柱冷冻法测定挥发性化合物。

Other Notes

我们提供各种色谱配件,包括 分析注射器

Legal Information

VOCOL is a registered trademark of Merck KGaA, Darmstadt, Germany

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Determination of volatile compounds in water by purging directly to a capillary column with whole column cryotrapping.
Pankow JF and Rosen ME.
Environmental Science & Technology, 22 (4), 398-405 (1988)
Zuleica A Camargo et al.
Logopedics, phoniatrics, vocology, 38(4), 157-166 (2013-07-06)
In this phonetic study, productions of the consonant in the stressed syllable position of the word arara as produced by 13 subjects with short and/or anterior lingual frenulum were compared before and after lingual frenectomy. The results from the measurement
Anne Rosing-Schow et al.
Logopedics, phoniatrics, vocology, 35(4), 166-168 (2010-10-12)
VoiceRelease is a progressively structured treatment system that aims to release the voice through muscle tension reduction by manual therapy, thereby facilitating healthy voice production. The VoiceRelease treatment should closely interact with functional voice training and should therefore be carried
Re: Bonilha HS, O'Shields M, Gerlach TT, Deliyski DD. Arytenoid adduction asymmetries in persons with and without voice disorders. Logoped Phoniatr Vocol. 2009 Aug 26:1-7. [E-pub ahead of print].
Gerhard Friedrich
Logopedics, phoniatrics, vocology, 35(3), 149-149 (2009-11-04)
Ben Barsties et al.
Logopedics, phoniatrics, vocology, 41(1), 27-32 (2014-08-05)
The aim of the study was to determine the impact of body height on speaking fundamental frequency (SF0) while controlling for as many as possible influencing factors such as habits, biophysical conditions, medication, diseases, and others. Fifty-eight females were analyzed

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持